MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitro

被引:18
作者
Bünger, CM
Jahnke, A
Stange, J
de Vos, P
Hopt, UT
机构
[1] Univ Rostock, Dept Surg, D-18055 Rostock, Germany
[2] Univ Rostock, Dept Med, Rostock, Germany
[3] Univ Groningen, Med Biol Sect, Dept Pathol & Lab Med, Groningen, Netherlands
[4] Univ Freiburg, Dept Surg, Freiburg, Germany
关键词
alginate; L929; fibroblasts; live-dead; microencapsulation; MTS;
D O I
10.1046/j.1525-1594.2002.06853.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Biomaterials such as applied in microcapsules may have harmful effects on encapsulated cells. Up to now, there are no adequate assays available for testing the function and viability of cells in capsules. Therefore, we investigated whether the combination of MTS proliferation assay and live-dead viability assay is suitable for testing microencapsulated L929 fibroblasts in long-time culture. Proliferation of L929 cells was shown by a significant increase of formazan absorbance within the first 3 weeks (Day 0: 0.132 +/- 0.047; Day 7: 0.404 +/- 0.101; Day 14: 0.728 +/- 0.239; Day 21: 0.877 +/- 0.224) followed by stagnation and decrease thereafter. This was confirmed by an increasing proportion of dead cells measured by the live-dead assay. Thus, proliferation of encapsulated L929 can be reliably investigated by the MTS assay. In combination with life-dead assays, the proliferation can be correlated to the survival rate of the encapsulated cells.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 24 条
[1]
BOAG AH, 1987, BIOTECHNOL BIOENG, V29, P954
[2]
USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY TO MEASURE VIABILITY AND PROLIFERATION OF LYMPHOKINE-DEPENDENT CELL-LINES [J].
BUTTKE, TM ;
MCCUBREY, JA ;
OWEN, TC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) :233-240
[3]
Encapsulation for somatic gene therapy [J].
Chang, PL .
BIOARTIFICIAL ORGANS II: TECHNOLOGY, MEDICINE, AND MATERIALS, 1999, 875 :146-158
[4]
GROWTH OF RECOMBINANT FIBROBLASTS IN ALGINATE MICROCAPSULES [J].
CHANG, PL ;
HORTELANO, G ;
TSE, M ;
AWREY, DE .
BIOTECHNOLOGY AND BIOENGINEERING, 1994, 43 (10) :925-933
[5]
Artificial cell biotechnology for medical applications [J].
Chang, TMS .
BLOOD PURIFICATION, 2000, 18 (02) :91-96
[6]
IMPLANTABLE BIOHYBRID ARTIFICIAL ORGANS [J].
COLTON, CK .
CELL TRANSPLANTATION, 1995, 4 (04) :415-436
[7]
USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY FOR CELL-GROWTH ASSAYS IN CULTURE [J].
CORY, AH ;
OWEN, TC ;
BARLTROP, JA ;
CORY, JG .
CANCER COMMUNICATIONS, 1991, 3 (07) :207-212
[8]
Upscaling the production of microencapsulated pancreatic islets [J].
DeVos, P ;
DeHaan, BJ ;
VanSchilfgaarde, R .
BIOMATERIALS, 1997, 18 (16) :1085-1090
[9]
DeVos P, 1997, DIABETOLOGIA, V40, P262
[10]
Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules [J].
DeVos, P ;
DeHaan, B ;
VanSchilfgaarde, R .
BIOMATERIALS, 1997, 18 (03) :273-278